Matches in Wikidata for { <http://www.wikidata.org/entity/Q57093731> ?p ?o ?g. }
- Q57093731 description "article scientifique publié en 2018" @default.
- Q57093731 description "artículu científicu" @default.
- Q57093731 description "im Jahr 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57093731 description "scholarly article by Giovanni Cazzaniga et al published January 2018 in Haematologica" @default.
- Q57093731 description "wetenschappelijk artikel" @default.
- Q57093731 description "наукова стаття, опублікована в січні 2018" @default.
- Q57093731 name "Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic l" @default.
- Q57093731 name "Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic l" @default.
- Q57093731 type Item @default.
- Q57093731 label "Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic l" @default.
- Q57093731 label "Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic l" @default.
- Q57093731 prefLabel "Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic l" @default.
- Q57093731 prefLabel "Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic l" @default.
- Q57093731 P1433 Q57093731-D990C1A5-C7C3-4208-97EC-CCEB6EB14CA1 @default.
- Q57093731 P1476 Q57093731-129C4498-303C-4BF2-A02C-56FC770AF494 @default.
- Q57093731 P2093 Q57093731-51D834FE-4DA6-42E0-8B58-0E9B82F64826 @default.
- Q57093731 P2093 Q57093731-67C4FE8B-07E6-4A54-BCEE-6008B54527A9 @default.
- Q57093731 P2093 Q57093731-6DFEE744-0E2E-48C4-8457-CC8B4C91F122 @default.
- Q57093731 P2093 Q57093731-A62D60BB-98D3-485B-93C3-F12CE270D5E7 @default.
- Q57093731 P2093 Q57093731-B552E2B9-2D4C-41E6-8BEF-6096B3851A19 @default.
- Q57093731 P2093 Q57093731-B86BDA81-5C05-4175-9EDC-1C80D480E7F3 @default.
- Q57093731 P2093 Q57093731-CD3EDB4D-A74B-46F9-9774-F67D31DF76D8 @default.
- Q57093731 P2093 Q57093731-EC27097D-2D2F-448D-8858-BE5E52E575FA @default.
- Q57093731 P2093 Q57093731-FF57CD74-DE5E-426A-9D58-414B5792AAE3 @default.
- Q57093731 P2860 Q57093731-22A58483-0656-48D3-8ACE-BEE7B99A8FE5 @default.
- Q57093731 P2860 Q57093731-288C93F4-F86C-4FB1-9BB2-C6556EF399E5 @default.
- Q57093731 P2860 Q57093731-29ED1C41-47D3-489A-A3B8-41F4169DD62F @default.
- Q57093731 P2860 Q57093731-2C3E3932-8CB3-43E3-BC4F-D829F56694C8 @default.
- Q57093731 P2860 Q57093731-2D70B2E8-8C20-4B08-A676-7D48346ED898 @default.
- Q57093731 P2860 Q57093731-3C6D0C66-C757-4D4F-BD14-449E60FA9757 @default.
- Q57093731 P2860 Q57093731-4AE21DCD-14CE-4AA4-8307-2CA701E95A52 @default.
- Q57093731 P2860 Q57093731-4E68959A-4533-4EEF-85A8-6E9DBE33F059 @default.
- Q57093731 P2860 Q57093731-4FCE52DA-38A6-42E5-888E-F0B1DF52D819 @default.
- Q57093731 P2860 Q57093731-67B5DA42-DD9C-4232-BC8E-1DEE4F71F51F @default.
- Q57093731 P2860 Q57093731-6AFE596E-9D8F-48D9-B7E2-A55FFB60C22B @default.
- Q57093731 P2860 Q57093731-70415A30-7E7A-4938-8062-FD5A9C6EC4F3 @default.
- Q57093731 P2860 Q57093731-7378E171-C77D-4EAA-878B-B39E7030569A @default.
- Q57093731 P2860 Q57093731-761F8D57-9901-4651-A041-D2DA3ED5FB01 @default.
- Q57093731 P2860 Q57093731-98FED059-4606-462F-9739-507561801214 @default.
- Q57093731 P2860 Q57093731-A3529A69-B617-41B8-9076-A48AC6A7D86C @default.
- Q57093731 P2860 Q57093731-CF969C6A-4AF4-49CB-9362-8ECE611FC59E @default.
- Q57093731 P2860 Q57093731-D9B4A9A0-A397-405C-A1B6-16ADAB4E9AEC @default.
- Q57093731 P2860 Q57093731-DBC55A9A-A6E4-446D-A4C3-FE62CFD070AE @default.
- Q57093731 P2860 Q57093731-DFBF6D14-B12F-4CFF-B8C1-894AE1A824D0 @default.
- Q57093731 P2860 Q57093731-EA746211-567B-4C44-B6B7-CBA03883FD1B @default.
- Q57093731 P2860 Q57093731-FAD6AA38-967D-4AC3-8AF6-90DE43683F32 @default.
- Q57093731 P2860 Q57093731-FE3ABE92-8937-44FB-ACF1-AA7A88C45023 @default.
- Q57093731 P304 Q57093731-01EA960E-51F6-47FE-9C27-07126C699B34 @default.
- Q57093731 P31 Q57093731-51BFB3B9-CA4D-45FE-B568-656D67CC680F @default.
- Q57093731 P356 Q57093731-24F4FE06-066E-4A77-BB0D-9EF17E51752E @default.
- Q57093731 P407 Q57093731-1B40B2AF-1A33-4779-B5A7-F2B4BCD55D2E @default.
- Q57093731 P433 Q57093731-558992E9-ADD3-4FCF-B672-9073F46E9034 @default.
- Q57093731 P478 Q57093731-157F24DC-3C12-4755-BD81-3C6F583497CC @default.
- Q57093731 P50 Q57093731-056FA9B0-7336-421B-8BD1-AEFF6BC9EE6E @default.
- Q57093731 P50 Q57093731-0B9A0A55-F4EC-4F08-8387-EF766AEA1ACF @default.
- Q57093731 P50 Q57093731-0F3C9FD7-35FA-49DB-99A4-EB8715705A6B @default.
- Q57093731 P50 Q57093731-12FDEEF3-C538-4A45-8053-156662F370BA @default.
- Q57093731 P50 Q57093731-202BCDE4-4B3D-402A-BE5E-764BC587BA91 @default.
- Q57093731 P50 Q57093731-32B00DF1-1D38-48AA-9E63-990D1C7FD53B @default.
- Q57093731 P50 Q57093731-49B5031B-2442-49CB-B34B-9A119C14D40B @default.
- Q57093731 P50 Q57093731-5A99CE28-43C1-487C-AD2D-5027EAA67547 @default.
- Q57093731 P50 Q57093731-5F7350AF-B7E8-46B9-95CD-F438CA34FEA6 @default.
- Q57093731 P50 Q57093731-84AC3FBE-DC05-44A8-9E1D-6760733C63B2 @default.
- Q57093731 P50 Q57093731-B4824251-C3AE-4733-A9FB-DD45ABB42821 @default.
- Q57093731 P50 Q57093731-C7D9ED93-AF7A-4933-881D-D2602D549313 @default.
- Q57093731 P50 Q57093731-E0DF7B49-8C48-4C70-B832-70809D9F0B72 @default.
- Q57093731 P50 Q57093731-EBC114AE-466C-4A4C-A1B4-DE97E7EB5AFB @default.
- Q57093731 P50 Q57093731-F8FBC064-56CB-4AF1-BBA7-C9EBF91A5210 @default.
- Q57093731 P50 Q57093731-F9E01BD6-B93C-43C0-8B6A-74AF605A79D4 @default.
- Q57093731 P577 Q57093731-111B3B8A-7855-426B-B173-BA9574A9E1C5 @default.
- Q57093731 P698 Q57093731-1C9D1E3D-8022-4352-AEC6-D944E8E785BF @default.
- Q57093731 P921 Q57093731-087A47A1-A4DE-4FCF-A7FB-F23914626DA8 @default.
- Q57093731 P921 Q57093731-0A0A5884-2DF1-4D65-8E2F-7E8E2B5D8D78 @default.
- Q57093731 P921 Q57093731-0EECE9A5-C317-4B2D-B352-8D8D938DCAC8 @default.
- Q57093731 P921 Q57093731-65485D50-3A1C-4C6D-A53D-12C15D168573 @default.
- Q57093731 P932 Q57093731-C9825E05-CDA8-4CA4-9579-343A50549135 @default.
- Q57093731 P356 HAEMATOL.2017.176917 @default.
- Q57093731 P698 29079599 @default.
- Q57093731 P1433 Q5638209 @default.
- Q57093731 P1476 "Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic l" @default.
- Q57093731 P2093 "Giovanni Cazzaniga" @default.
- Q57093731 P2093 "Giulia M Ferrari" @default.
- Q57093731 P2093 "Hans O Madsen" @default.
- Q57093731 P2093 "Jeremy Hancock" @default.
- Q57093731 P2093 "Julia Alten" @default.
- Q57093731 P2093 "Paola De Lorenzo" @default.
- Q57093731 P2093 "Rolf Köhler" @default.
- Q57093731 P2093 "Udo Zur Stadt" @default.
- Q57093731 P2093 "Vincent van der Velden" @default.
- Q57093731 P2860 Q26778461 @default.
- Q57093731 P2860 Q31099184 @default.
- Q57093731 P2860 Q34488796 @default.
- Q57093731 P2860 Q34598903 @default.
- Q57093731 P2860 Q34810036 @default.
- Q57093731 P2860 Q35553341 @default.
- Q57093731 P2860 Q35561038 @default.
- Q57093731 P2860 Q36201257 @default.
- Q57093731 P2860 Q36366185 @default.
- Q57093731 P2860 Q37412290 @default.
- Q57093731 P2860 Q40519372 @default.